|1.||Ye, Jian-Lin: 1 article (04/2012)|
|2.||Lu, Yi: 1 article (04/2012)|
|3.||Song, Hui-Zhu: 1 article (04/2012)|
|4.||Yue, Lin-Feng: 1 article (04/2012)|
|5.||Chen, Dai: 1 article (04/2012)|
|6.||Zhu, Mei-Feng: 1 article (04/2012)|
|7.||Kou, Xin-Hui: 1 article (04/2012)|
04/01/2012 - "Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet."
04/01/2012 - "Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARα-mediated lipid catabolism. "
04/01/2012 - "The amelioration of insulin resistance by bilobetin is closely related to its hypolipidaemic effect. "
04/01/2012 - "Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. "
|4.||very low density lipoprotein triglyceride